Matthew F. Thomas

879 total citations
32 papers, 525 citations indexed

About

Matthew F. Thomas is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Matthew F. Thomas has authored 32 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 16 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Matthew F. Thomas's work include Pneumonia and Respiratory Infections (12 papers), Mycobacterium research and diagnosis (8 papers) and Cystic Fibrosis Research Advances (6 papers). Matthew F. Thomas is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Mycobacterium research and diagnosis (8 papers) and Cystic Fibrosis Research Advances (6 papers). Matthew F. Thomas collaborates with scholars based in United Kingdom, Australia and France. Matthew F. Thomas's co-authors include David A. Spencer, Julia Clark, Stephen P. Rushton, Mohamed A. Elemraid, Malcolm Brodlie, Andrew R. Gennery, Katherine Eastham, John D. Perry, Aaron Gardner and R. Gorton and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and European Respiratory Journal.

In The Last Decade

Matthew F. Thomas

28 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew F. Thomas United Kingdom 14 339 208 107 79 71 32 525
Raquel Martínez Spain 13 346 1.0× 237 1.1× 50 0.5× 91 1.2× 77 1.1× 27 632
Shin Yamashiro Japan 12 154 0.5× 273 1.3× 60 0.6× 44 0.6× 20 0.3× 18 448
João Gouveia Portugal 11 233 0.7× 42 0.2× 159 1.5× 39 0.5× 25 0.4× 25 425
Antônio Carlos Moreira Lemos Brazil 13 177 0.5× 165 0.8× 179 1.7× 14 0.2× 33 0.5× 37 426
Qijian Cheng China 12 277 0.8× 161 0.8× 168 1.6× 53 0.7× 8 0.1× 31 568
Miguel F. Carrascosa Spain 11 75 0.2× 122 0.6× 138 1.3× 22 0.3× 64 0.9× 43 416
C. Andréjak France 12 212 0.6× 93 0.4× 179 1.7× 24 0.3× 91 1.3× 26 357
Danyang She China 7 252 0.7× 112 0.5× 99 0.9× 70 0.9× 11 0.2× 13 393
Hans‐Georg Posselt Germany 14 141 0.4× 463 2.2× 137 1.3× 32 0.4× 36 0.5× 38 808
C Mayaud France 10 261 0.8× 134 0.6× 173 1.6× 14 0.2× 17 0.2× 73 472

Countries citing papers authored by Matthew F. Thomas

Since Specialization
Citations

This map shows the geographic impact of Matthew F. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew F. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew F. Thomas more than expected).

Fields of papers citing papers by Matthew F. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew F. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew F. Thomas. The network helps show where Matthew F. Thomas may publish in the future.

Co-authorship network of co-authors of Matthew F. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew F. Thomas. A scholar is included among the top collaborators of Matthew F. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew F. Thomas. Matthew F. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Matthew F., et al.. (2022). Reducing prescribing errors: making electronic prescribing work for cystic fibrosis inpatients. Archives of Disease in Childhood Education & Practice. 108(2). 112–114.
2.
Thomas, Matthew F., et al.. (2021). Bronchioloalveolar carcinoma arising in congenital pulmonary airway malformation in a neonate. Pediatric Pulmonology. 56(5). 1261–1263. 3 indexed citations
3.
4.
Harris, Caroline, Malcolm Brodlie, Christopher J. O’Brien, & Matthew F. Thomas. (2020). Successful biodegradable stent insertion in an infant with severe bronchomalacia and cystic fibrosis. Journal of Cystic Fibrosis. 20(2). e13–e15.
5.
Gardner, Aaron, et al.. (2020). Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis. Journal of Cystic Fibrosis. 20(5). 737–741. 19 indexed citations
6.
Haq, Iram, Mike Althaus, Aaron Gardner, et al.. (2020). Clinical and molecular characterization of the R751L-CFTR mutation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 320(2). L288–L300. 5 indexed citations
7.
Perry, Audrey, John M. Davison, A. E. Johnston, et al.. (2019). An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation. BMC Pulmonary Medicine. 19(1). 19–19. 26 indexed citations
8.
Thomas, Matthew F., et al.. (2018). Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy. Journal of Pediatric Endocrinology and Metabolism. 31(9). 1019–1022. 3 indexed citations
9.
Gardner, Aaron, et al.. (2018). Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry. Clinical Infectious Diseases. 68(5). 731–737. 29 indexed citations
10.
Tissot, Adrien, Matthew F. Thomas, Paul A. Corris, & Malcolm Brodlie. (2018). NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice. BMC Pulmonary Medicine. 18(1). 86–86. 26 indexed citations
11.
Thomas, Matthew F., et al.. (2017). Congenital Lung Agenesis: Incidence and Outcome in the North of England. Birth Defects Research. 109(11). 857–859. 7 indexed citations
12.
Brodlie, Malcolm, Adrien Tissot, Matthew F. Thomas, & Paul A. Corris. (2017). NonTuberculous Mycobacteria Infection and Lung Transplantation in Cystic Fibrosis: A Worldwide Survey of Clinical Practice. The Journal of Heart and Lung Transplantation. 36(4). S95–S96.
13.
Hasan, Asif, F.K. Gould, Su Bunn, et al.. (2017). Successful outcome following pneumonectomy in a teenage boy with cystic fibrosis: a case report. BMC Pulmonary Medicine. 17(1). 17–17. 2 indexed citations
14.
Perry, Audrey, D. Kenna, Amanda Jones, et al.. (2015). A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis. Journal of Cystic Fibrosis. 15(2). 186–191. 34 indexed citations
15.
Elemraid, Mohamed A., Matthew F. Thomas, Alasdair Blain, et al.. (2014). Risk factors for the development of pleural empyema in children. Pediatric Pulmonology. 50(7). 721–726. 58 indexed citations
16.
Elemraid, Mohamed A., David A. Spencer, Stephen P. Rushton, et al.. (2014). Accuracy of the Interpretation of Chest Radiographs for the Diagnosis of Paediatric Pneumonia. PLoS ONE. 9(8). e106051–e106051. 64 indexed citations
17.
Elemraid, Mohamed A., Stephen P. Rushton, Matthew F. Thomas, et al.. (2014). Utility of inflammatory markers in predicting the aetiology of pneumonia in children. Diagnostic Microbiology and Infectious Disease. 79(4). 458–462. 31 indexed citations
18.
Elemraid, Mohamed A., Andrew D. Sails, Matthew F. Thomas, et al.. (2013). Pneumococcal diagnosis and serotypes in childhood community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease. 76(2). 129–132. 6 indexed citations
19.
Spencer, David A., et al.. (2012). National surveillance of paediatric empyema in the UK; the UK-ESPE study. 40. 2946. 2 indexed citations
20.
Desai, Meena, et al.. (1994). Neonatal screening for congenital hypothyroidism using the filter paper thyroxine technique.. PubMed. 100. 36–42. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel Martínez Breakdown of academic impact, for papers by Shin Yamashiro Breakdown of academic impact, for papers by João Gouveia Breakdown of academic impact, for papers by Antônio Carlos Moreira Lemos Breakdown of academic impact, for papers by Qijian Cheng Breakdown of academic impact, for papers by Miguel F. Carrascosa Breakdown of academic impact, for papers by C. Andréjak Breakdown of academic impact, for papers by Danyang She Breakdown of academic impact, for papers by Hans‐Georg Posselt Breakdown of academic impact, for papers by C Mayaud
Rankless by CCL
2026